Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zevcet Yilmaz"'
Clinical and Demographic Features of Twenty- Nine Patients with Psoriatic Arthritis 'Sine Psoriasis'
Autor:
Yusuf Karabulut, Duygu Kurtulus, Fatih Saritas, Sercan Gucenmez, Zevcet Yilmaz, Sevtap Simsek, Irfan Esen
Publikováno v:
Selcuk Tip Dergisi.
Amaç: Psoriatik Artrit (PsA), sedef hastalığı (PsO) olan hastaların %10-30'unu etkileyen kronik ilerleyici inflamatuar bir hastalıktır. "PsA Sine sedef hastalığı" terimi, "cilt belirtileri olmadan PsA teşhisi konan hastaları" tanımlamak
Autor:
Meral Kayıkçıoğlu, Gökhan Keser, Kenan Aksu, Hakan Emmungil, Özgül Soysal Gündüz, Zevcet Yilmaz, Melike Kalfa, Nurullah Akkoc, Fatos Onen, Vedat Inal, Oktay Musayev, Servet Akar
Publikováno v:
European Journal of Rheumatology
WOS: 000451335600007
PubMed ID: 30501851
Objective: Pulmonary hypertension (PH) may occur in Takayasu arteritis (TA), mostly due to pulmonary arteritis, but also due to left heart disease and/or chronic thromboembolism (CTE). Using transtho
PubMed ID: 30501851
Objective: Pulmonary hypertension (PH) may occur in Takayasu arteritis (TA), mostly due to pulmonary arteritis, but also due to left heart disease and/or chronic thromboembolism (CTE). Using transtho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50a8c4610dd6221d0c076845dac20a7
https://avesis.deu.edu.tr/publication/details/104fe504-efdc-4713-b39a-fe86e472ea7d/oai
https://avesis.deu.edu.tr/publication/details/104fe504-efdc-4713-b39a-fe86e472ea7d/oai
Atypical hemolytic uremic syndrome (aHUS) is a disorder characterized by a propensity to thrombotic microangiopathy (TMA) due to defective regulation of the alternative complement pathway. Mutations in genes encoding complement factor H (CFH) and com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d091da6bb9edc101bef0c57a4e2c0fb
https://avesis.deu.edu.tr/publication/details/7d3190b2-15e4-49c8-b23a-549b1bdfe148/oai
https://avesis.deu.edu.tr/publication/details/7d3190b2-15e4-49c8-b23a-549b1bdfe148/oai
Autor:
Sercan Gücenmez, Hayriye Koçanaoğulları, Hakan Emmungil, Yasemin Kabasakal, Melike Kalfa, Gonca Karabulut, Celal Cinar, Zevcet Yilmaz
Publikováno v:
European Journal of Rheumatology. 3:136-138
WOS: 000388377000008
PubMed ID: 27733945
Segmental arterial mediolysis (SAM) is a rare, nonarteriosclerotic, noninflammatory vascular disease and mostly affects medium-to-large sized abdominal arteries as well as presents with hemorrhages i
PubMed ID: 27733945
Segmental arterial mediolysis (SAM) is a rare, nonarteriosclerotic, noninflammatory vascular disease and mostly affects medium-to-large sized abdominal arteries as well as presents with hemorrhages i
Autor:
Hakan, Emmungil, Raika, Durusoy, Melike, Kalfa, Figen, Yargucu Zihni, Mustafa, Özmen, Gökhan, Keser, Sercan, Gücenmez, Zevcet, Yilmaz, Kenan, Aksu
Publikováno v:
Clinical and experimental rheumatology. 33(6 Suppl 94)
Thiopurine S-methyltransferase (TPMT) is the key enzyme inactivating azathioprine (AZA), an immunosuppressive agent commonly used for treating inflammatory diseases including Behçet's disease (BD), systemic lupus erythematosus (SLE) and systemic vas
Publikováno v:
Annals of the Rheumatic Diseases. 72:A909.1-A909
Background Primary Sjogren’s syndrome (pSjS) is a chronic autoimmune disease primarily involving the exocrine glands. The clinical picture of pSjS ranges from exocrinopathy to systemic disease. Environmental and hormonal factors, such as vitamin-D
Publikováno v:
Annals of the Rheumatic Diseases. 72:A927.1-A927
Objectives To evaluate the efficacy and safety of interferon alpha 2a (IFNa) in the treatment of Behcet patients with severe uveitis resistant and/or intolerant to conventional immunosuppressive (IS) agents such as azathioprine (AZA) and cyclosporine
Autor:
Sercan Gücenmez, H. Koçanaoğulları, C. Çavuşoğlu, Gonca Karabulut, Vedat Inal, Zevcet Yilmaz, Melike Kalfa, Hakan Emmungil
Publikováno v:
Annals of the Rheumatic Diseases. 72:A634.1-A634
Background Tumor Necrosis Factor-α (TNF-α) inhibitors have increased risk of reactivation of latent tuberculosis infection (LTBI). Screening for LTBI before initiating anti-TNF therapy is recommended.(1) Tuberculin skin test (TST) and in vitro inte
Publikováno v:
Annals of the Rheumatic Diseases. 72:A928.3-A928
Objectives To evaluate the efficacy and safety of anti-tumor necrosis factor-alpha (anti-TNF-α) agents including infliximab (IFX) and adalimumab (ADA) in the treatment of refractory Behcet uveitis. Methods This retrospective study included 12 cases